2015-2027 Global Rivaroxaban Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

Publisher Name :
Date: 26-May-2020
No. of pages: 104

The worldwide market for Rivaroxaban is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered

Johnson & Johnson

Bayer

Major Types Covered

2.5 mg

10 mg

15 mg

20 mg

Major Applications Covered

Venous thromboembolism (VTE)

Acute coronary syndrome (ACS)

Top Countries Data Covered in This Report

United States

Canada

Germany

UK

France

Italy

Spain

Russia

Netherlands

Turkey

Switzerland

Sweden

Poland

Belgium

China

Japan

South Korea

Australia

India

Taiwan

Indonesia

Thailand

Philippines

Malaysia

Brazil

Mexico

Argentina

Columbia

Chile

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2027

2015-2027 Global Rivaroxaban Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 Key Findings of the Study

3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Rivaroxaban Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Rivaroxaban Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 Value Chain of the Rivaroxaban Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 Global Rivaroxaban Market-Segmentation by Type
5.1 2.5 mg
5.2 10 mg
5.3 15 mg
5.4 20 mg

6 Global Rivaroxaban Market-Segmentation by Application
6.1 Venous thromboembolism (VTE)
6.2 Acute coronary syndrome (ACS)

7 Global Rivaroxaban Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 Competitive Intelligence - Company Profiles
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Profile
8.1.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.1.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.2 Bayer
8.2.1 Bayer Profile
8.2.2 Bayer Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Bayer Product/Solution Launches and Enhancements Analysis
8.2.4 Bayer Business Overview/Recent Development/Acquisitions

9 Global Rivaroxaban Market-Segmentation by Geography

10 North America
10.1 North America Rivaroxaban Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Rivaroxaban Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Rivaroxaban Production Analysis from 2015-2020
10.4 North America Rivaroxaban Consumption Analysis from 2015-2020
10.5 North America Rivaroxaban Import and Export from 2015-2020
10.6 North America Rivaroxaban Value, Production and Market Share by Type (2015-2020)
10.7 North America Rivaroxaban Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Rivaroxaban by Country (United States, Canada)
10.8.1 North America Rivaroxaban Sales by Country (2015-2020)
10.8.2 North America Rivaroxaban Consumption Value by Country (2015-2020)
10.9 North America Rivaroxaban Market PEST Analysis

11 Europe
11.1 Europe Rivaroxaban Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Rivaroxaban Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Rivaroxaban Production Analysis from 2015-2020
11.4 Europe Rivaroxaban Consumption Analysis from 2015-2020
11.5 Europe Rivaroxaban Import and Export from 2015-2020
11.6 Europe Rivaroxaban Value, Production and Market Share by Type (2015-2020)
11.7 Europe Rivaroxaban Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Rivaroxaban by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Rivaroxaban Sales by Country (2015-2020)
11.8.2 Europe Rivaroxaban Consumption Value by Country (2015-2020)
11.9 Europe Rivaroxaban Market PEST Analysis

12 Asia-Pacific
12.1 Asia-Pacific Rivaroxaban Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Rivaroxaban Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Rivaroxaban Production Analysis from 2015-2020
12.4 Asia-Pacific Rivaroxaban Consumption Analysis from 2015-2020
12.5 Asia-Pacific Rivaroxaban Import and Export from 2015-2020
12.6 Asia-Pacific Rivaroxaban Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Rivaroxaban Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Rivaroxaban by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Rivaroxaban Sales by Country (2015-2020)
12.8.2 Asia-Pacific Rivaroxaban Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Rivaroxaban Market PEST Analysis

13 Latin America
13.1 Latin America Rivaroxaban Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Rivaroxaban Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Rivaroxaban Production Analysis from 2015-2020
13.4 Latin America Rivaroxaban Consumption Analysis from 2015-2020
13.5 Latin America Rivaroxaban Import and Export from 2015-2020
13.6 Latin America Rivaroxaban Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Rivaroxaban Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Rivaroxaban by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Rivaroxaban Sales by Country (2015-2020)
13.8.2 Latin America Rivaroxaban Consumption Value by Country (2015-2020)
13.9 Latin America Rivaroxaban Market PEST Analysis

14 Middle East & Africa
14.1 Middle East & Africa Rivaroxaban Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Rivaroxaban Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Rivaroxaban Production Analysis from 2015-2020
14.4 Middle East & Africa Rivaroxaban Consumption Analysis from 2015-2020
14.5 Middle East & Africa Rivaroxaban Import and Export from 2015-2020
14.6 Middle East & Africa Rivaroxaban Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Rivaroxaban Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Rivaroxaban by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Rivaroxaban Sales by Country (2015-2020)
14.8.2 Middle East & Africa Rivaroxaban Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Rivaroxaban Market PEST Analysis

15 Future Forecast of the Global Rivaroxaban Market from 2020-2027
15.1 Future Forecast of the Global Rivaroxaban Market from 2020-2027 Segment by Region
15.2 Global Rivaroxaban Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Rivaroxaban Consumption and Growth Rate Forecast by Application (2020-2027)

16 Appendix
16.1 Methodology
16.2 Research Data Source

List of Tables and Figures
Global Rivaroxaban Market Value ($) and Growth Rate of Rivaroxaban from 2015-2027
Global Rivaroxaban Production and Growth Rate Segment by Product Type from 2015-2027
Global Rivaroxaban Consumption and Growth Rate Segment by Application from 2015-2027
Figure Rivaroxaban Picture
Table Product Specifications of Rivaroxaban
Table Driving Factors for this Market
Table Industry News of Rivaroxaban Market
Figure Value Chain Status of Rivaroxaban
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Rivaroxaban Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Rivaroxaban Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure 2.5 mg of Rivaroxaban
Figure 10 mg of Rivaroxaban
Figure 15 mg of Rivaroxaban
Figure 20 mg of Rivaroxaban
Table Global Rivaroxaban Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Rivaroxaban Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Venous thromboembolism (VTE) of Rivaroxaban
Figure Acute coronary syndrome (ACS) of Rivaroxaban
Table Global Rivaroxaban Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Rivaroxaban Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Rivaroxaban
Figure Online Channel of Rivaroxaban
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Rivaroxaban Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer Sales and Growth Rate from 2015-2020
Figure Bayer Revenue ($) and Global Market Share from 2015-2020
Table Bayer Rivaroxaban Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Rivaroxaban Production Value ($) by Region from 2015-2020
Table Global Rivaroxaban Production Value Share by Region from 2015-2020
Table Global Rivaroxaban Production by Region from 2015-2020
Table Global Rivaroxaban Consumption Value ($) by Region from 2015-2020
Table Global Rivaroxaban Consumption by Region from 2015-2020
Table North America Rivaroxaban Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Rivaroxaban Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Rivaroxaban Import and Export from 2015-2020
Table North America Rivaroxaban Value ($) by Type (2015-2020)
Table North America Rivaroxaban Production by Type (2015-2020)
Table North America Rivaroxaban Consumption by Application (2015-2020)
Table North America Rivaroxaban Consumption by Country (2015-2020)
Table North America Rivaroxaban Consumption Value ($) by Country (2015-2020)
Figure North America Rivaroxaban Market PEST Analysis
Table Europe Rivaroxaban Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Rivaroxaban Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Rivaroxaban Import and Export from 2015-2020
Table Europe Rivaroxaban Value ($) by Type (2015-2020)
Table Europe Rivaroxaban Production by Type (2015-2020)
Table Europe Rivaroxaban Consumption by Application (2015-2020)
Table Europe Rivaroxaban Consumption by Country (2015-2020)
Table Europe Rivaroxaban Consumption Value ($) by Country (2015-2020)
Figure Europe Rivaroxaban Market PEST Analysis
Table Asia-Pacific Rivaroxaban Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Rivaroxaban Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Rivaroxaban Import and Export from 2015-2020
Table Asia-Pacific Rivaroxaban Value ($) by Type (2015-2020)
Table Asia-Pacific Rivaroxaban Production by Type (2015-2020)
Table Asia-Pacific Rivaroxaban Consumption by Application (2015-2020)
Table Asia-Pacific Rivaroxaban Consumption by Country (2015-2020)
Table Asia-Pacific Rivaroxaban Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Rivaroxaban Market PEST Analysis
Table Latin America Rivaroxaban Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Rivaroxaban Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Rivaroxaban Import and Export from 2015-2020
Table Latin America Rivaroxaban Value ($) by Type (2015-2020)
Table Latin America Rivaroxaban Production by Type (2015-2020)
Table Latin America Rivaroxaban Consumption by Application (2015-2020)
Table Latin America Rivaroxaban Consumption by Country (2015-2020)
Table Latin America Rivaroxaban Consumption Value ($) by Country (2015-2020)
Figure Latin America Rivaroxaban Market PEST Analysis
Table Middle East & Africa Rivaroxaban Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Rivaroxaban Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Rivaroxaban Import and Export from 2015-2020
Table Middle East & Africa Rivaroxaban Value ($) by Type (2015-2020)
Table Middle East & Africa Rivaroxaban Production by Type (2015-2020)
Table Middle East & Africa Rivaroxaban Consumption by Application (2015-2020)
Table Middle East & Africa Rivaroxaban Consumption by Country (2015-2020)
Table Middle East & Africa Rivaroxaban Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Rivaroxaban Market PEST Analysis
Table Global Rivaroxaban Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Rivaroxaban Production and Growth Rate Forecast by Region (2020-2027)
Table Global Rivaroxaban Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Rivaroxaban Production and Growth Rate Forecast by Type (2020-2027)
Table Global Rivaroxaban Consumption and Growth Rate Forecast by Application (2020-2027)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs